Genmab Investor Relations Material
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.
Upcoming events for
Q2 20222022-08-10
Latest company events
More about Genmab
Ticker symbol
GMAB
Country
Denmark
About the company
Investor Relations Page
Dig deeper into the Genmab fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
